Clear 523 Results Filter Filter Results Type: Press Release Abiomed Announces Q2 FY 2020 Revenue of $205 Million and 294% Operating Margin Type: Press Release FDA Post Approval Study Demonstrates Timely Identification of Right Heart Failure and Early Use of Impella RP Leads to Higher Survival Type: Press Release Abiomed Second Quarter Fiscal 2020 Earnings and Conference Call Notification Type: Press Release Study Demonstrates Early Use of Impella Can Increase Survival in Cardiogenic Shock Escalation Protocols Initiated Type: Press Release PROTECT III Presented at TCT 2019 – Clinical Data Demonstrates Protected PCI with Impella is Associated with Improved Outcomes Type: Press Release Abiomed Receives FDA PMA Approval for Impella 55 with SmartAssist a Minimally Invasive Forward Flow Heart Pump Type: Press Release Highest Court in Germany Affirms Strength of Abiomed’s Patents Type: Press Release Abiomed to Highlight Importance of Optimal PCI Treatment to Improve Outcomes for High-Risk Patients at TCT 2019 Type: Press Release Abiomed to Present at the Morgan Stanley Global Healthcare Conference Type: Press Release Impella® SmartAssist Platform Launches at ESC Designed to Further Improve Patient Outcomes 1 2 3 4 …
